Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool

Molecular Genetics and Metabolism

Volumn 110, Issue 1-2, 2013, Pages 25-34

  Iacobazzi, Vito ^a,b   Castegna, Alessandra ^a   Infantino, Vittoria ^a,c   Andria, Generoso ^d  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF BASILICATA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Biomarker; Epigenetics; Methylation; Mitochondrial DNA

Indexed keywords

BISULFITE; MITOCHONDRIAL DNA; RESTRICTION ENDONUCLEASE; RNA 12S; BIOLOGICAL MARKER; S ADENOSYLHOMOCYSTEINE;

DEGENERATIVE DISEASE; DISEASE MARKER; DNA METHYLATION; ELECTRON TRANSPORT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; MITOCHONDRION;

BIOLOGICAL MARKERS; DNA METHYLATION; DNA, MITOCHONDRIAL; EPIGENESIS, GENETIC; HUMANS; MITOCHONDRIA; S-ADENOSYLHOMOCYSTEINE;

EID: 84882847104     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.07.012     Document Type: Review

References (128)

1. Lee T., Zhai J., Meyers C. Conservation and divergence in eukaryotic DNA methylation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9027-9028.
2. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
3. Dawid I.B. 5-Methylcytidylic acid: absence from mitochondrial DNA of frogs and HeLa cells. Science 1974, 184:80-81.
4. Cummings D.J., Tait A., Goddard J.M. Methylated bases in DNA from Paramecium aurelia. Biochim. Biophys. Acta 1974, 374:1-11.
5. Nass M.M. Differential methylation of mitochondrial and nuclear DNA in cultured mouse, hamster and virus-transformed hamster cells. In vivo and in vitro methylation. J. Mol. Biol. 1973, 80:155-175.
6. Pollack Y., Kasir J., Shemer R., Metzger S., Szyf M. Methylation pattern of mouse mitochondrial DNA. Nucleic Acids Res. 1984, 12:4811-4824.
7. Shmookler Reis R.J., Goldstein S. Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation. J. Biol. Chem. 1983, 258:9078-9085.
8. Groot G.S., Kroon A.M. Mitochondrial DNA from various organisms does not contain internally methylated cytosines in -CCGG- sequences. Biochim. Biophys. Acta 1979, 564:355-357.
9. Makaeva M., Taniguchi T., Higashi H., Sigimura H., Sugano K., Kanno T. Methylation of mitochondrial DNA is not a useful marker for cancer detection. Clin. Chem. 2004, 258:1480-1481. (2004).
10. Satoh M., Kuroiwa T. Organization of multiple nucleoids and DNA molecules in mitochondria of a human cell. Exp. Cell Res. 1991, 196:137-140.
11. Infantino V., Castegna A., Iacobazzi F., Spera I., Scala I., Andria G., Iacobazzi V. Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome. Mol. Genet. Metab. 2011, 102:378-382.
12. Shock L.S., Thakkar P.V., Peterson E.J., Moran R.G., Taylor S.M. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3630-3635.
13. Chestnut B.A., Chang Q., Price A., Lesuisse C., Wong M., Martin L.J. Epigenetic regulation of motor neuron cell death through DNA methylation. J. Neurosci. Off. J. Soc. Neurosci. 2011, 31:16619-16636.
14. Manev H., Dzitoyeva S. Progress in mitochondrial epigenetics Biomol. Concepts 2013, (in press). 10.1515/bmc-2013-0005.
15. Hoque M.O. DNA methylation changes in prostate cancer: current developments and future clinical implementation. Expert Rev. Mol. Diagn. 2009, 9:243-257.
16. Anglim P.P., Alonzo T.A., Laird-Offringa I.A. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol. Cancer 2008, 7:81.
17. Levenson V.V. DNA methylation as a universal biomarker. Expert Rev. Mol. Diagn. 2010, 10:481-488.
18. Shivapurkar N., Gazdar A.F. DNA methylation based biomarkers in non-invasive cancer screening. Curr. Mol. Med. 2010, 10:123-132.
19. Zeisel S.H. Importance of methyl donors during reproduction. Am. J. Clin. Nutr. 2009, 89:673S-677S.
20. Wang F.K., Koch J., Stokstad E.L. Folate coenzyme pattern, folate linked enzymes and methionine biosynthesis in rat liver mitochondria. Biochem. Z. 1967, 346:458-466.
21. Naviaux R.K. Mitochondrial control of epigenetics. Cancer Biol. Ther. 2008, 7:1191-1193.
22. Christensen K.E., MacKenzie R.E. Mitochondrial one-carbon metabolism is adapted to the specific needs of yeast, plants and mammals. BioEssay 2006, 28:595-605.
23. Agrimi G., Di Noia M.A., Marobbio C.M., Fiermonte G., Lasorsa F.M., Palmieri F. Identification of the human mitochondrial S-adenosylmethionine transporter: bacterial expression, reconstitution, functional characterization and tissue distribution. Biochem. J. 2004, 379:183-190.
24. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 2000, 71:121-138.
25. Moat S.J., Lang D., McDowell I.F., Clarke Z.L., Madhavan A.K., Lewis M.J., Goodfellow J. Folate, homocysteine, endothelial function and cardiovascular disease. J. Nutr. Biochem. 2004, 15:64-79.
26. Kim Y.I. Role of folate in colon cancer development and progression. J. Nutr. 2003, 133:3731S-3739S.
27. Mattson M.P., Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003, 26:137-146.
28. Tangney C.C., Aggarwal N.T., Li H., Wilson R.S., Decarli C., Evans D.A., Morris M.C. Vitamin B12, cognition, and brain MRI measures: a cross-sectional examination. Neurology 2011, 77:1276-1282.
29. de Jager C.A., Oulhaj A., Jacoby R., Refsum H., Smith A.D. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int. J. Geriatr. Psychiatry 2012, 27:592-600.
30. Wald D.S., Kasturiratne A., Simmonds M. Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers Dement. 2011, 7:412-417.
31. Kronenberg G., Harms C., Sobol R.W., Cardozo-Pelaez F., Linhart H., Winter B., Balkaya M., Gertz K., Gay S.B., Cox D., Eckart S., Ahmadi M., Juckel G., Kempermann G., Hellweg R., Sohr R., Hortnagl H., Wilson S.H., Jaenisch R., Endres M. Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J. Neurosci. Off. J. Soc. Neurosci. 2008, 28:7219-7230.
32. Nilsson K., Gustafson L., Hultberg B. Relation between plasma homocysteine and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2002, 14:7-12.
33. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 1998, 55:1449-1455.
34. James S.J., Melnyk S., Pogribna M., Pogribny I.P., Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 2002, 132(8 suppl.):2361S-2366S.
35. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J., Staden R., Young I.G. Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465.
36. Falkenberg M., Larsson N.G., Gustafsson C.M. DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem. 2007, 76:679-699.
37. Kukat C., Wurm C.A., Spahr H., Falkenberg M., Larsson N.G., Jakobs S. Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:13534-13539.
38. Kaufman D.B.A., Durisic N., Mativetsky J.M., Costantino S., Hancock M.A., Grutter P., Shoubridge E.A. The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol. Biol. Cell 2007, 18:3225-3236.
39. Rebelo A.P., Williams S.L., Moraes C.T. In vivo methylation of mtDNA reveals the dynamics of protein-mtDNA interactions. Nucleic Acids Res. 2009, 37:6701-6715.
40. Lee S.H. Expression of the mitochondrial ATP6 gene and TFAM in Down syndrome. Mol. Cell 2002, 15:181-185.
41. Marcelino L.A., Thilly W.G. Mitochondrial mutagenesis in human cells and tissues. Mutat. Res. 1999, 434:177-203.
42. Lightowlers R.N., Chinnery P.F., Turnbull D.M., Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 1997, 13:450-455.
43. Laird P.W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 2003, 3:253-266.
44. Dehan P., Kustermans G., Guenin S., Horion J., Boniver J., Delvenne P. DNA methylation and cancer diagnosis: new methods and applications. Expert Rev. Mol. Diagn. 2009, 9:651-657.
45. Ellinger J., Albers P., Perabo F.G., Muller S.C., von Ruecker A., Bastian P.J. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J. Urol. 2009, 182:324-329.
46. Kamat A.A., Bischoff F.Z., Dang D., Baldwin M.F., Han L.Y., Lin Y.G., Merritt W.M., Landen C.N., Lu C., Gershenson D.M., Simpson J.L., Sood A.K. Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma. Cancer Biol. Ther. 2006, 5:1369-1374.
47. Terry M.B., Delgado-Cruzata L., Vin-Raviv N., Wu H.C., Santella R.M. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011, 6:828-837.
48. Papageorgiou E.A., Karagrigoriou A., Tsaliki E., Velissariou V., Carter N.P., Patsalis P.C. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat. Med. 2011, 17:510-513.
49. Valenti D., Manente G.A., Moro L., Marra E., Vacca R.A. Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway. Biochem. J. 2011, 435:679-688.
50. Arbuzova S. Why it is necessary to study the role of mitochondrial genome in trisomy 21 pathogenesis Down syndrome. Res. Pract. 1998, 5:126-130.
51. Arbuzova S., Hutchin T., Cuckle H. Mitochondrial dysfunction and Down's syndrome. BioEssay 2002, 24:681-684.
52. Coskun P., Wyrembak J., Schriner S.E., Chen H.W., Marciniack C., Laferla F., Wallace D.C. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 2012, 1820:553-564.
53. Scafone T., Cristiani C., Crocco P., D'Aquila P., Dato S., Giordano M., Pisani F., Tallaro F., Rose G., Bellizzi D., Passarino G. Evidence of methylation within the control region of human mitochondrial DNA. 12th International FISV Congress, Rome, Italy 2012, 9.9.
54. Cheng J.C., Weisenberger D.J., Gonzales F.A., Liang G., Xu G.L., Hu Y.G., Marquez V.E., Jones P.A. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells. Mol. Cell. Biol. 2004, 24:1270-1278.
55. Appleton K., Mackay H.J., Judson I., Plumb J.A., McCormick C., Strathdee G., Lee C., Barrett S., Reade S., Jadayel D., Tang A., Bellenger K., Mackay L., Setanoians A., Schatzlein A., Twelves C., Kaye S.B., Brown R. Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2007, 25:4603-4609.
56. Chen H., Dzitoyeva S., Manev H. Effect of valproic acid on mitochondrial epigenetics. Eur. J. Pharmacol. 2012, 690:51-59.
57. Scarpulla R.C. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 2002, 286:81-89.
58. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
59. Carabelli J., Burgueno A.L., Rosselli M.S., Gianotti T.F., Lago N.R., Pirola C.J., Sookoian S. High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. J. Cell. Mol. Med. 2011, 15:1329-1338.
60. Pirola C.J., Fernandez Gianotti T., Burgueno A.L., Rey-Funes M., Loidl C.F., Mallardi P., San Martino J., Castano G.O., Sookoian S. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 2012, (in press). 10.1136/gutjnl-2012-302962.
61. Mathers J.C., Strathdee G., Relton C.L. Induction of epigenetic alterations by dietary and other environmental factors. Adv. Genet. 2010, 71:3-39.
62. Byun H.M., Panni T., Motta V., Hou L., Nordio F., Apostoli P., Bertazzi P.A., Baccarelli A.A. Effects of airborne pollutants on mitochondrial DNA methylation particle and fibre. Toxicology 2013, 10:18.
63. Giordano M., Cristiani C., Crocco P., D'Aquila P., De Rango F., Pisani F., Scafone T., Tallaro F., Rose G., Passarino G., Bellizzi D. Methylation of the human mitochondrial 12S rRNA gene is correlated with aging. 12th International FISV Congress, Rome, Italy 2012, 9.5.
64. Swerdlow R.H. Brain aging, Alzheimer's disease, and mitochondria. Biochim. Biophys. Acta 2011, 1812:1630-1639.
65. Dzitoyeva S., Chen H., Manev H. Effect of aging on 5-hydroxymethylcytosine in brain mitochondria. Neurobiol. Aging 2012, 33:2881-2891.
66. Bellizzi D., D'Aquila P., Scafone T., Giordano M., Riso V., Riccio A., Passarino G. The control region of mitochondrial DNA shows an unusual CpG and non-CpG methylation pattern. DNA Res. 2013, 1-11.
67. Clayton D.A. Transcription and replication of mitochondrial DNA. Hum. Reprod. 2000, 15:11-17.
68. McCulloch V., Seidel-Rogol B.L., Shadel G.S. A human mitochondrial transcription factor is related to RNA adenine methyltransferases and binds S-adenosylmethionine. Mol. Cell Biol. 2002, 22:1116-1125.
69. Shadel G.S. Coupling the mitochondrial transcription machinery to human diseases. Trends Genet. 2004, 20:513-518.
70. Metodiev M.D., Lesko N., Park C.B., Camara Y., Shi Y., Wibom R., Hultenby K., Gustafsson C.M., Larsson N.G. Methylation of 12S rRNA is necessary for in vivo stability of the small subunit of the mammalian mitochondrial ribosome. Cell Metab. 2009, 9:386-397.
71. Cotney J., McKay S.E., Shadel G.S. Elucidation of separate, but collaborative functions of the rRNA methyltransferase-related human mitochondrial transcription factors B1 and B2 in mitochondrial biogenesis reveals new insight into maternally inherited deafness. Hum. Mol. Genet. 2009, 18:2670-2682.
72. Bykhovskaya Y., Mengesha E., Wang D., Yang H., Estivill X., Shohat M., Fischel-Ghodsian N. Human mitochondrial transcription factor B1 as a modifier gene for hearing loss associated with the mitochondrial A1555G mutation. Mol. Genet. Metab. 2004, 82:27-32.
73. Davenport L., Taylor R.H., Dubin D.T. Comparison of human and hamster mitochondrial transfer RNA. Physical properties and methylation status. Biochim. Biophys. Acta 1976, 447:285-293.
74. Dubin D.T. Methylated nucleotide content of mitochondrial ribosomal RNA from hamster cells. J. Mol. Biol. 1974, 84:257-273.
75. Sirum-Connolly K., Peltier J.M., Crain P.F., McCloskey J.A., Mason T.L. Implications of a functional large ribosomal RNA with only three modified nucleotides. Biochimie 1995, 77:30-39.
76. Schones D.E., Zhao K. Genome-wide approaches to studying chromatin modifications. Nat. Rev. Genet 2008, 9:179-191.
77. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002, 21:5400-5413.
78. Song L., James S.R., Kazim L., Karpf A.R. Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Chem. 2005, 77:504-510.
79. The ENCODE Project Consortium Nature 2007, 447:799-816.
80. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
81. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., Lee W., Mendenhall E., O'Donovan A., Presser A., Russ C., Xie X., Meissner A., Wernig M., Jaenisch R., Nusbaum C., Lander E.S., Bernstein B.E. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
82. Guenther M.G., Levine S.S., Boyer L.A., Jaenisch R., Young R.A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007, 130:77-88.
83. Robertson G., Hirst M., Bainbridge M., Bilenky M., Zhao Y., Zeng T., Euskirchen G., Bernier B., Varhol R., Delaney A., Thiessen N., Griffith O.L., He A., Marra M., Snyder M., Jones S. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 2007, 4:651-657.
84. Kucej M., Kucejova B., Subramanian R., Chen X.J., Butow R.A. Mitochondrial nucleoids undergo remodeling in response to metabolic cues. J. Cell Sci. 2008, 121:1861-1868.
85. Mukhopadhyay R., Yu W., Whitehead J., Xu J., Lezcano M., Pack S., Kanduri C., Kanduri M., Ginjala V., Vostrov A., Quitschke W., Chernukhin I., Klenova E., Lobanenkov V., Ohlsson R. The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res. 2004, 14:1594-1602.
86. Cross S.H., Charlton J.A., Nan X., Bird A.P. Purification of CpG islands using a methylated DNA binding column. Nat. Genet. 1994, 6:236-244.
87. Weber M., Davies J.J., Wittig D., Oakeley E.J., Haase M., Lam W.L., Schubeler D. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 2005, 37:853-862.
88. Keshet I., Schlesinger Y., Farkash S., Rand E., Hecht M., Segal E., Pikarski E., Young R.A., Niveleau A., Cedar H., Simon I. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet. 2006, 38:149-153.
89. Hayatsu H. Discovery of bisulfite-mediated cytosine conversion to uracil, the key reaction for DNA methylation analysis-a personal account. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2008, 84:321-330.
90. Wang R.Y., Gehrke C.W., Ehrlich M. Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res. 1980, 8:4777-4790.
91. Pomraning K.R., Smith K.M., Freitag M. Genome-wide high throughput analysis of DNA methylation in eukaryotes. Methods 2009, 47:142-150.
92. van der Ploeg L.H., Flavell R.A. DNA methylation in the human gamma delta beta-globin locus in erythroid and nonerythroid tissues. Cell 1980, 19:947-958.
93. Huang Y., Pastor W.A., Shen Y., Tahiliani M., Liu D.R., Rao A. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010, 5:e8888.
94. Reinders J., Delucinge Vivier C., Theiler G., Chollet D., Descombes P., Paszkowski J. Genome-wide, high-resolution DNA methylation profiling using bisulfite-mediated cytosine conversion. Genome Res. 2008, 18:469-476.
95. N Cancer Genome Atlas Research Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
96. Byun H.M., Siegmund K.D., Pan F., Weisenberger D.J., Kanel G., Laird P.W., Yang A.S. Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. Hum. Mol. Genet. 2009, 18:4808-4817.
97. Katari S., Turan N., Bibikova M., Erinle O., Chalian R., Foster M., Gaughan J.P., Coutifaris C., Sapienza C. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum. Mol. Genet. 2009, 18:3769-3778.
98. Martinez R., Martin-Subero J.I., Rohde V., Kirsch M., Alaminos M., Fernandez A.F., Ropero S., Schackert G., Esteller M. A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 2009, 4:255-264.
99. Christensen B.C., Houseman E.A., Marsit C.J., Zheng S., Wrensch M.R., Wiemels J.L., Nelson H.H., Karagas M.R., Padbury J.F., Bueno R., Sugarbaker D.J., Yeh R.F., Wiencke J.K., Kelsey K.T. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009, 5:e1000602.
100. Steemers F.J., Gunderson K.L. Whole genome genotyping technologies on the BeadArray platform. Biotechnol. J. 2007, 2:41-49.
101. Bibikova M., Le J., Barnes B., Saedinia-Melnyk S., Zhou L., Shen R., Gunderson K.L. Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 2009, 1:177-200.
102. Cokus S.J., Feng S., Zhang X., Chen Z., Merriman B., Haudenschild C.D., Pradhan S., Nelson S.F., Pellegrini M., Jacobsen S.E. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 2008, 452:215-219.
103. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., Edsall L., Antosiewicz-Bourget J., Stewart R., Ruotti V., Millar A.H., Thomson J.A., Ren B., Ecker J.R. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
104. Maekawa M., Sugano K., Ushiama M., Fukayama N., Nomoto K., Kashiwabara H., Fujita S., Kakizoe T. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer. Clin Chem Lab Med 2001, 39:121-128.
105. Hong E.E., Okitsu C.Y., Smith A.D., Hsieh C.L. Regionally-specific and genome-wide analyses conclusively demonstrate the absence of CpG methylation in human mitochondrial DNA. Mol. Cell Biol. 2013, 33:2683-2690.
106. Hayashizaki Y., Hirotsune S., Okazaki Y., Hatada I., Shibata H., Kawai J., Hirose K., Watanabe S., Fushiki S., Wada S., et al. Restriction landmark genomic scanning method and its various applications. Electrophoresis 1993, 14:251-258.
107. Costello J.F., Fruhwald M.C., Smiraglia D.J., Rush L.J., Robertson G.P., Gao X., Wright F.A., Feramisco J.D., Peltomaki P., Lang J.C., Schuller D.E., Yu L., Bloomfield C.D., Caligiuri M.A., Yates A., Nishikawa R., Su Huang H., Petrelli N.J., Zhang X., O'Dorisio M.S., Held W.A., Cavenee W.K., Plass C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 2000, 24:132-138.
108. Allegrucci C., Wu Y.Z., Thurston A., Denning C.N., Priddle H., Mummery C.L., Ward-van Oostwaard D., Andrews P.W., Stojkovic M., Smith N., Parkin T., Jones M.E., Warren G., Yu L., Brena R.M., Plass C., Young L.E. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Hum. Mol. Genet. 2007, 16:1253-1268.
109. Song F., Smith J.F., Kimura M.T., Morrow A.D., Matsuyama T., Nagase H., Held W.A. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3336-3341.
110. Liang G., Gonzalgo M.L., Salem C., Jones P.A. Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction. Methods 2002, 27:150-155.
111. Frigola J., Ribas M., Risques R.A., Peinado M.A. Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res. 2002, 30:e28.
112. Estecio M.R., Yan P.S., Ibrahim A.E., Tellez C.S., Shen L., Huang T.H., Issa J.P. High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res. 2007, 17:1529-1536.
113. Omura N., Li C.P., Li A., Hong S.M., Walter K., Jimeno A., Hidalgo M., Goggins M. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol. Ther. 2008, 7:1146-1156.
114. Shen L., Toyota M., Kondo Y., Lin E., Zhang L., Guo Y., Hernandez N.S., Chen X., Ahmed S., Konishi K., Hamilton S.R., Issa J.P. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18654-18659.
115. Ordway J.M., Budiman M.A., Korshunova Y., Maloney R.K., Bedell J.A., Citek R.W., Bacher B., Peterson S., Rohlfing T., Hall J., Brown R., Lakey N., Doerge R.W., Martienssen R.A., Leon J., McPherson J.D., Jeddeloh J.A. Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS One 2007, 2:e1314.
116. Irizarry R.A., Ladd-Acosta C., Carvalho B., Wu H., Brandenburg S.A., Jeddeloh J.A., Wen B., Feinberg A.P. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res. 2008, 18:780-790.
117. Ibrahim A.E., Thorne N.P., Baird K., Barbosa-Morais N.L., Tavare S., Collins V.P., Wyllie A.H., Arends M.J., Brenton J.D. MMASS: an optimized array-based method for assessing CpG island methylation. Nucleic Acids Res. 2006, 34:e136.
118. Brunner A.L., Johnson D.S., Kim S.W., Valouev A., Reddy T.E., Neff N.F., Anton E., Medina C., Nguyen L., Chiao E., Oyolu C.B., Schroth G.P., Absher D.M., Baker J.C., Myers R.M. Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res. 2009, 19:1044-1056.
119. Berman B.P., Weisenberger D.J., Laird P.W. Locking in on the human methylome. Nat. Biotechnol. 2009, 27:341-342.
120. Tarasova G.V., Nayakshina T.N., Degtyarev S.K. Substrate specificity of new methyl-directed DNA endonuclease GlaI BMC. Mol. Biol. 2008, 9:7.
121. Tost J., Schatz P., Schuster M., Berlin K., Gut I.G. Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. Nucleic Acids Res. 2003, 31:e50.
122. Ehrich M., Nelson M.R., Stanssens P., Zabeau M., Liloglou T., Xinarianos G., Cantor C.R., Field J.K., van den Boom D. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15785-15790.
123. Branton D., Deamer D.W., Marziali A., Bayley H., Benner S.A., Butler T., Di Ventra M., Garaj S., Hibbs A., Huang X., Jovanovich S.B., Krstic P.S., Lindsay S., Ling X.S., Mastrangelo C.H., Meller A., Oliver J.S., Pershin Y.V., Ramsey J.M., Riehn R., Soni G.V., Tabard-Cossa V., Wanunu M., Wiggin M., Schloss J.A. The potential and challenges of nanopore sequencing. Nat. Biotechnol. 2008, 26:1146-1153.
124. Clarke J., Wu H.C., Jayasinghe L., Patel A., Reid S., Bayley H. Continuous base identification for single-molecule nanopore DNA sequencing. Nat. Nanotechnol. 2009, 4:265-270.
125. Liu L., van Groen T., Kadish I., Li Y., Wang D., James S.R., Karpf A.R., Tollefsbol T.O. Insufficient DNA methylation affects healthy aging and promotes age-related health problems. Clin. Epigenetics 2011, 2:349-360.
126. Ho A.S., Turcan S., Chan T.A. Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management. Oncotarget Ther. 2013, 6:223-232.
127. Chen Z., Li Y., Zhang H., Huang P., Luthra R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010, 29:4362-4368.
128. Li J., Donath S., Li Y., Qin D., Prabhakar B.S., Li P. miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet. 2010, 6:e1000795.